• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用D-最优混合设计通过分散聚合优化新型隐形聚乳酸基纳米颗粒的制备

Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design.

作者信息

Adesina Simeon K, Wight Scott A, Akala Emmanuel O

机构信息

Department of Pharmaceutical Sciences, Center for Drug Research and Development (CDRD), Howard University , Washington DC , USA and.

出版信息

Drug Dev Ind Pharm. 2014 Nov;40(11):1547-56. doi: 10.3109/03639045.2013.838578. Epub 2013 Sep 23.

DOI:10.3109/03639045.2013.838578
PMID:24059281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677483/
Abstract

PURPOSE

Nanoparticle size is important in drug delivery. Clearance of nanoparticles by cells of the reticuloendothelial system has been reported to increase with increase in particle size. Further, nanoparticles should be small enough to avoid lung or spleen filtering effects. Endocytosis and accumulation in tumor tissue by the enhanced permeability and retention effect are also processes that are influenced by particle size. We present the results of studies designed to optimize cross-linked biodegradable stealth polymeric nanoparticles fabricated by dispersion polymerization.

METHODS

Nanoparticles were fabricated using different amounts of macromonomer, initiators, crosslinking agent and stabilizer in a dioxane/DMSO/water solvent system. Confirmation of nanoparticle formation was by scanning electron microscopy (SEM). Particle size was measured by dynamic light scattering (DLS). D-optimal mixture statistical experimental design was used for the experimental runs, followed by model generation (Scheffe polynomial) and optimization with the aid of a computer software. Model verification was done by comparing particle size data of some suggested solutions to the predicted particle sizes.

RESULTS AND CONCLUSION

Data showed that average particle sizes follow the same trend as predicted by the model. Negative terms in the model corresponding to the cross-linking agent and stabilizer indicate the important factors for minimizing particle size.

摘要

目的

纳米颗粒大小在药物递送中至关重要。据报道,随着颗粒大小增加,网状内皮系统细胞对纳米颗粒的清除作用增强。此外,纳米颗粒应足够小以避免肺部或脾脏的过滤效应。通过增强的渗透和滞留效应实现的内吞作用以及在肿瘤组织中的积累也是受颗粒大小影响的过程。我们展示了旨在优化通过分散聚合制备的交联可生物降解隐形聚合物纳米颗粒的研究结果。

方法

在二氧六环/二甲基亚砜/水溶剂体系中,使用不同量的大分子单体、引发剂、交联剂和稳定剂制备纳米颗粒。通过扫描电子显微镜(SEM)确认纳米颗粒的形成。通过动态光散射(DLS)测量颗粒大小。实验运行采用D-最优混合统计实验设计,随后生成模型(谢弗多项式)并借助计算机软件进行优化。通过将一些建议溶液的颗粒大小数据与预测颗粒大小进行比较来进行模型验证。

结果与结论

数据表明平均颗粒大小与模型预测的趋势相同。模型中与交联剂和稳定剂对应的负项表明了使颗粒大小最小化的重要因素。

相似文献

1
Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design.使用D-最优混合设计通过分散聚合优化新型隐形聚乳酸基纳米颗粒的制备
Drug Dev Ind Pharm. 2014 Nov;40(11):1547-56. doi: 10.3109/03639045.2013.838578. Epub 2013 Sep 23.
2
D-Optimal mixture experimental design for stealth biodegradable crosslinked docetaxel-loaded poly-ε-caprolactone nanoparticles manufactured by dispersion polymerization.用于通过分散聚合法制备的隐形可生物降解交联多西他赛负载聚己内酯纳米颗粒的D-最优混合实验设计
Pharmazie. 2015 Mar;70(3):165-76.
3
Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization.分散聚合法制备的可生物降解纳米粒子的计算机优化
Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010047. doi: 10.3390/ijerph13010047.
4
Computer Optimization of Stealth Biodegradable Polymeric Dual-loaded Nanoparticles for Cancer Therapy Using Central Composite Face-centered Design.使用中心复合表面设计对用于癌症治疗的隐形可生物降解聚合物双载纳米颗粒进行计算机优化。
Pharm Nanotechnol. 2020;8(2):108-132. doi: 10.2174/2211738508666200224110410.
5
Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.用于制药应用的聚己内酯纳米颗粒粒径分布控制策略。
J Colloid Interface Sci. 2008 Jun 15;322(2):505-15. doi: 10.1016/j.jcis.2008.03.033. Epub 2008 Mar 21.
6
Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.用于紫杉醇递送的氧化还原响应性聚合物纳米粒的制备及体外性质。
Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):454-63. doi: 10.1016/j.colsurfb.2011.06.009. Epub 2011 Jun 15.
7
Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.由聚乳酸-聚乙二醇共聚物稳定的氧化石墨烯用于紫杉醇的控释。
Eur J Pharm Biopharm. 2015 Jun;93:18-26. doi: 10.1016/j.ejpb.2015.03.022. Epub 2015 Mar 24.
8
Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.基于聚(3-羟基丁酸-co-3-羟基戊酸)(PHBV)纳米粒的长效胰岛素制剂的制备:制备、优化、表征和体外评价。
Pharm Dev Technol. 2019 Feb;24(2):176-188. doi: 10.1080/10837450.2018.1452936. Epub 2018 Mar 26.
9
Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy.载来曲唑聚(DL-丙交酯)纳米粒的制备及特性研究及其在乳腺癌治疗中的药物递送。
Pharm Dev Technol. 2019 Feb;24(2):235-242. doi: 10.1080/10837450.2018.1455698. Epub 2018 Apr 5.
10
pH-Sensitive Polymeric Nanoparticles Fabricated by Dispersion Polymerization for the Delivery of Bioactive Agents.通过分散聚合制备的用于生物活性剂递送的pH敏感聚合物纳米颗粒。
Pharm Nanotechnol. 2017;5(1):44-66. doi: 10.2174/2211738505666170110102320.

引用本文的文献

1
Dispersion polymerization induced self-assembly (pisa) techniques for the fabrication of polymeric nanoparticles for biomedical applications.用于生物医学应用的聚合物纳米颗粒制备的分散聚合诱导自组装(PISA)技术。
Nanotechnol Lett. 2023 Jan;8(1):1-15. Epub 2023 Jan 28.
2
Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer.用于治疗前列腺癌的负载布鲁斯他汀和多西他赛的纳米颗粒的制备、优化及体外评价
Pharmaceutics. 2024 Jan 16;16(1):114. doi: 10.3390/pharmaceutics16010114.
3
Cellular uptake and cytotoxicity studies of pH-responsive polymeric nanoparticles fabricated by dispersion polymerization.通过分散聚合法制备的pH响应性聚合物纳米颗粒的细胞摄取和细胞毒性研究
J Nanosci Nanomed. 2018 Sep;2(1):3-18. Epub 2018 Apr 12.
4
Fabrication of Paclitaxel and 17AAG-loaded Poly-ε-Caprolactone Nanoparticles for Breast Cancer Treatment.用于乳腺癌治疗的载有紫杉醇和17AAG的聚ε-己内酯纳米颗粒的制备
J Pharm Drug Deliv Res. 2021 Jan;10(1). Epub 2021 Jan 11.
5
Studies on polyethylene glycol-monoclonal antibody conjugates for fabrication of nanoparticles for biomedical applications.用于生物医学应用的纳米颗粒制备的聚乙二醇-单克隆抗体缀合物的研究。
J Nanosci Nanomed. 2020 Jul;4(2):1-9. Epub 2020 Feb 3.
6
Drug Combinations in Breast Cancer Therapy.乳腺癌治疗中的药物联合应用
Pharm Nanotechnol. 2019;7(1):3-23. doi: 10.2174/2211738507666190122111224.
7
Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment.通过分散聚合法制备的负载抗逆转录病毒药物的纳米颗粒在治疗艾滋病毒/艾滋病方面具有潜力。
Infect Dis (Auckl). 2016 Mar 20;9:21-32. doi: 10.4137/IDRT.S38108. eCollection 2016.
8
Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound.用纳米颗粒包裹的靶向小分子蛋白磷酸酶-1的化合物激活HIV-1。
Sci Pharm. 2015 Jun 22;83(3):535-48. doi: 10.3797/scipharm.1502-01. Print 2015 Jul-Sep.
9
Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization.分散聚合法制备的可生物降解纳米粒子的计算机优化
Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010047. doi: 10.3390/ijerph13010047.
10
Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.用于HIV治疗的外源性小干扰RNA递送的纳米技术方法。
Mol Pharm. 2015 Dec 7;12(12):4175-87. doi: 10.1021/acs.molpharmaceut.5b00335. Epub 2015 Nov 9.

本文引用的文献

1
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.使用聚乙二醇包被的空间稳定纳米球进行药物的静脉控释给药。
Adv Drug Deliv Rev. 1995 Sep;16(2-3):215-233. doi: 10.1016/0169-409X(95)00026-4.
2
Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.白蛋白肠溶包衣喷雾干燥微球制剂的混合设计实施。
Drug Dev Ind Pharm. 2013 Feb;39(2):164-75. doi: 10.3109/03639045.2012.664148. Epub 2012 May 17.
3
Has nanotechnology led to improved therapeutic outcomes?纳米技术是否提高了治疗效果?
Drug Dev Ind Pharm. 2012 Feb;38(2):158-70. doi: 10.3109/03639045.2011.597764.
4
Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.载纳曲酮可生物降解微球的体外释放度、降解和热性能研究。
Drug Dev Ind Pharm. 2011 Jun;37(6):673-84. doi: 10.3109/03639045.2010.535540. Epub 2011 Mar 30.
5
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.载紫杉醇的聚乙二醇化聚己内酯纳米粒增强抗脑胶质瘤作用的体内外评价。
Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005. Epub 2010 Oct 8.
6
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.粒径和表面电荷对聚合物纳米粒子细胞摄取和体内分布的影响。
Biomaterials. 2010 May;31(13):3657-66. doi: 10.1016/j.biomaterials.2010.01.065. Epub 2010 Feb 6.
7
Factors affecting the clearance and biodistribution of polymeric nanoparticles.影响聚合物纳米颗粒清除率和生物分布的因素。
Mol Pharm. 2008 Jul-Aug;5(4):505-15. doi: 10.1021/mp800051m. Epub 2008 Aug 4.
8
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?可生物降解聚合物纳米颗粒的新概念化疗:我们目前处于什么阶段?
Nanomedicine (Lond). 2006 Oct;1(3):297-309. doi: 10.2217/17435889.1.3.297.
9
The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells.载有紫杉醇的纳米颗粒联合辐射对缺氧MCF - 7细胞的影响。
J Clin Pharm Ther. 2007 Feb;32(1):41-7. doi: 10.1111/j.1365-2710.2007.00796.x.
10
Nanotechnology: intelligent design to treat complex disease.纳米技术:治疗复杂疾病的智能设计
Pharm Res. 2006 Jul;23(7):1417-50. doi: 10.1007/s11095-006-0284-8. Epub 2006 Jun 21.